Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4050699rdf:typepubmed:Citationlld:pubmed
pubmed-article:4050699lifeskim:mentionsumls-concept:C0175677lld:lifeskim
pubmed-article:4050699lifeskim:mentionsumls-concept:C0001271lld:lifeskim
pubmed-article:4050699lifeskim:mentionsumls-concept:C0027096lld:lifeskim
pubmed-article:4050699lifeskim:mentionsumls-concept:C0009915lld:lifeskim
pubmed-article:4050699lifeskim:mentionsumls-concept:C0039082lld:lifeskim
pubmed-article:4050699lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:4050699lifeskim:mentionsumls-concept:C1155229lld:lifeskim
pubmed-article:4050699lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:4050699pubmed:issue10lld:pubmed
pubmed-article:4050699pubmed:dateCreated1985-11-4lld:pubmed
pubmed-article:4050699pubmed:abstractTextTo better understand the pathogenesis of the post-cardiac injury syndrome (PCIS) 2 models of cardiac injury were studied. One hundred twenty-nine patients who underwent cardiac surgery and 80 patients with acute myocardial infarction (AMI) were prospectively followed and the levels of anti-heart antibodies (AHA), anti-actin antibodies (AAA) and anti-myosin antibodies (AMA) were determined. In the surgical group, PCIS developed in 27 patients (21%) and incomplete PCIS in 36 (28%). In the AMI group, PCIS did not develop in any patient, but incomplete PCIS developed in 11 patients (14%) (p less than 0.001). The surgical group showed a significantly higher humoral immune response than the AMI group when analyzed for AHA and anti-contractile protein antibodies. After cardiac surgery, AHA developed in 59 patients (46%), AAA developed in 33 (26%) and AMA developed in 49 (38%); in the AMI group, significant levels of AHA, AAA and AMA developed in 16 (20%), 7 (9%) and 13 patients (16%), respectively. These studies show a significant correlation between the PCIS clinical classification and auto-antibodies raised against heart contractile proteins.lld:pubmed
pubmed-article:4050699pubmed:languageenglld:pubmed
pubmed-article:4050699pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4050699pubmed:citationSubsetAIMlld:pubmed
pubmed-article:4050699pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4050699pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4050699pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4050699pubmed:statusMEDLINElld:pubmed
pubmed-article:4050699pubmed:monthOctlld:pubmed
pubmed-article:4050699pubmed:issn0002-9149lld:pubmed
pubmed-article:4050699pubmed:authorpubmed-author:Vandekerckhov...lld:pubmed
pubmed-article:4050699pubmed:authorpubmed-author:ClementDDlld:pubmed
pubmed-article:4050699pubmed:authorpubmed-author:De BuyzereMMlld:pubmed
pubmed-article:4050699pubmed:authorpubmed-author:AlgoedLLlld:pubmed
pubmed-article:4050699pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:4050699pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:4050699pubmed:authorpubmed-author:RobbrechtJJlld:pubmed
pubmed-article:4050699pubmed:authorpubmed-author:De LangheJJlld:pubmed
pubmed-article:4050699pubmed:issnTypePrintlld:pubmed
pubmed-article:4050699pubmed:day1lld:pubmed
pubmed-article:4050699pubmed:volume56lld:pubmed
pubmed-article:4050699pubmed:ownerNLMlld:pubmed
pubmed-article:4050699pubmed:authorsCompleteYlld:pubmed
pubmed-article:4050699pubmed:pagination631-3lld:pubmed
pubmed-article:4050699pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:meshHeadingpubmed-meshheading:4050699-...lld:pubmed
pubmed-article:4050699pubmed:year1985lld:pubmed
pubmed-article:4050699pubmed:articleTitlePost-cardiac injury syndrome and an increased humoral immune response against the major contractile proteins (actin and myosin).lld:pubmed
pubmed-article:4050699pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:4050699pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4050699lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4050699lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4050699lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4050699lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4050699lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4050699lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4050699lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4050699lld:pubmed